What Causes a Vein Occlusion?
Several factors combine to bring on an occlusion. The usual situation is that something
causes the blood flow in a retinal vein to slow down so much that it permits a clot to
form there. The clot prevents blood from flowing freely.
The most common reason for slowed venous blood flow
is, surprisingly, a hardened artery (arteriosclerosis). If a stiff artery happens to lie
across a vein and compresses it, it can slow the flow of blood in that vein in the same
way that a log across a stream can obstruct the flow of water. Because arteriosclerosis
occurs so often in people who have hypertension it is considered to be a risk factor for
the development of BRVO.
Other conditions that can lead to a BRVO are venous
inflammation (vasculitis), which can plug the vein , and some rare blood conditions that
produce a greater-than-normal tendency for blood to clot. Even estrogen medication (as in
oral contraceptives) can introduce a slight risk of blood clotting.
Examination
You will have a complete eye examination and vision test. Your pupils will be dilated
(enlarged) with eye drops so the insides of both eyes can be studied. An ophthalmoscope
and slit lamp (clinical microscope) are instruments used for looking inside the eyes; they
are especially useful for studying the retina and its blood supply.
Retinal photographs may be taken to help determine
the extent of the problem. An angiogram
(photographs of blood vessels) may also be made. For this test, an orange-colored dye
(fluorescein) is injected into a vein in your arm and is immediately followed by a series
of retinal photographs that track the dye, and time its flow, as it travels through the
eye's blood vessels. The angiogram helps identify the exact site of the vein's blockage,
the extent of damage to capillaries (the smallest retinal blood vessels), and whether or
not neovascularization has developed.
Because BRVO can be associated with medical
conditions that affect the rest of the body (high blood pressure, for example, which also
increases the risk of a heart attack or stroke), you may be referred to an internist or
family physician for a complete check-up after your eye examination.
Treatment
Once a BRVO has occurred, there is no simple way to speed the healing process along.
Eventually, over several months, the blocked vein may re-open on its own, or some nearby
blood vessels (called colaterals) may develop and reroute the blood flow around the site
of blockage. Either of these may help restore at least part of the lost retinal function.
If neovascularization develops, a type of laser
surgery called panretinal photocoagulation (PRP) can help reduce or even eliminate the
abnormal blood vessels. PRP is not intended to improve vision directly. It reduces the
risk of further vision loss from internal bleeding or, possibly, from a retinal
detachment.
PRP is performed on an outpatient basis and is a
painless treatment. It consists of making hundreds of tiny laser burns in and around the
damaged part of the retina. If the neovascularization does not respond to this treatment
by decreasing substantially within a month or so, additional laser PRP can be applied.
After a BRVO, the central retina (macula) sometimes
remains swollen for months, reducing vision significantly. To help minimize the macular
swelling, another type of laser treatment (called grid-pattern) can sometimes be used. Its
risks and intended results, however , are distinctly different from the laser PRP
technique used for treating neovascularization.
Prognosis
If you are under age 50 or so, a BRVO may not impair your vision much, if at all. Even if
vision is reduced initially, it has some potential for returning, perhaps even to its
previous level, over the next few months. If neovascularization occurs, it can be treated
with laser PRP.
If you are older, good visual recovery is not as
likely. But even if some reduced vision remains, the degree of impairment is not likely to
be severe.
Regular follow-up examinations are important to
protect your eyesight. Your eyes should be checked regularly for potential late
complications, such as neovascularization or macular edema, and for the development of a
second vascular occlusion in either eye.